JAMA Medical News

Discussion of major 2022–2024 shifts toward earlier detection and intervention for ASCVD risk. New screening ages and intervals, including young adult and childhood checks. Introduction of the Prevent ASCVD calculator and 30-year risk use. Updated LDL-C treatment targets and one-time lipoprotein(a) testing. Expanded roles for ApoB, coronary calcium scoring, and statin recommendations for CKD and HIV patients.

Samantha Anderer, a JAMA Medical News staff writer who covers health policy, breaks down the EPA's rollback of heavy metal air-pollution limits. She explains the switch back to older mercury and metal standards. Short segments cover mercury and prenatal neurotoxicity, other toxic metals, and wider EPA deregulation moves and their health implications.

Kate Schweitzer, Associate Managing Editor at JAMA Medical News and reporter on public health, talks PrEP access and policy. She outlines PrEP’s evolving options, from injectables to on-demand. She highlights access barriers: stigma, insurance and Medicaid hurdles, and high-cost injectables. She also covers funding cuts, modeling risks to progress, and local innovations like pharmacist prescribing and telehealth.

Rita Rubin, lead senior staff writer for JAMA Medical News who covers clinical medicine and health policy, walks through the rise of patient-facing AI. She discusses ChatGPT Health, what these tools can and cannot do, triage and accuracy concerns, privacy and HIPAA gaps, and government plans to build autonomous AI for conditions like heart failure.

Samantha Anderer, a JAMA Medical News staff writer covering research and health topics, discusses a long-term study comparing low-carb, low-fat, and food quality for heart health. She explains how healthy versions of both diets cut heart disease risk, while unhealthy versions raise it. The conversation highlights focusing on whole foods and warns against relying on processed, protein-marketed products.

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "What Nutrition Experts Say About the New Dietary Guidelines for Americans." Related Content: What Nutrition Experts Say About the New Dietary Guidelines for Americans

Rita Rubin, Lead Senior Staff Writer who covers health policy and clinical topics, explains how recent ICE actions are disrupting care. She discusses rescinded protections that exposed hospitals, patients skipping appointments or shifting to virtual care, arrests near medical sites, community health programs stepping in, and controversies over CMS data sharing and legal pushback.

They discuss myocarditis after mRNA COVID-19 vaccination and who is most affected. The conversation covers cytokines and proposed biological mechanisms behind inflammation. They describe mouse experiments testing genistein to blunt cytokine surges and reduce heart injury. Future research directions and vaccine safety context are also highlighted.

Rita Rubin, Lead Senior Staff Writer for JAMA Medical News who covers clinical and public health reporting, walks through three upcoming weight-loss drugs. Short takes on injectable semaglutide doses versus an oral option. Trial results and combo therapy outcomes are discussed. Practical factors for choosing treatments like dosing, side effects, and insurance are highlighted.

Rita Rubin, lead senior staff writer who reports on biomedical research, explores a study tying stress to links between depression, anxiety, and heart disease. She breaks down biobank data and how stress markers may connect brain, immune, and autonomic systems. Practical stress-reduction tips like sleep, meditation, and yoga are discussed for protecting heart health.